tiprankstipranks
Trending News
More News >
InnoCare Pharma Ltd. (HK:9969)
:9969
Hong Kong Market

InnoCare Pharma Ltd. (9969) Income Statement

Compare
2 Followers

InnoCare Pharma Ltd. Income Statement

Last quarter (Q3 2025), InnoCare Pharma Ltd.'s total revenue was ¥419.47M, an increase of 50.88% from the same quarter last year. In Q3, InnoCare Pharma Ltd.'s net income was ¥-37.50M. See InnoCare Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.01B¥ 738.54M¥ 625.40M¥ 1.04B¥ 1.36M
Gross Profit
¥ 871.01M¥ 610.10M¥ 482.01M¥ 977.37M¥ 1.36M
Operating Expenses
¥ 1.40B¥ 1.26B¥ 1.25B¥ 1.14B¥ 560.35M
Depreciation and Amortization
¥ 57.99M¥ 92.62M¥ 68.40M¥ 33.71M¥ 2.07M
EBITDA
¥ -463.49M¥ -516.55M¥ -808.28M¥ 16.23M¥ -556.92M
Operating Income
¥ -525.78M¥ -651.15M¥ -770.40M¥ -181.10M¥ -558.99M
Other Income/Expenses
¥ 73.19M¥ 6.95M¥ -123.32M¥ 160.98M¥ 167.12M
Pretax Income
¥ -452.59M¥ -644.21M¥ -893.73M¥ -20.12M¥ -391.87M
Net Income
¥ -440.63M¥ -631.26M¥ -886.59M¥ -64.55M¥ -391.39M
Per Share Metrics
Basic EPS
¥ -0.26¥ -0.37¥ -0.60¥ -0.05¥ -0.40
Diluted EPS
¥ -0.26¥ -0.37¥ -0.60¥ -0.05¥ -0.40
Weighted Average Shares Outstanding
1.69B 1.71B 1.48B 1.37B 967.58M
Weighted Average Shares Outstanding (Diluted)
1.69B 1.71B 1.48B 1.37B 967.58M
Currency in CNY

InnoCare Pharma Ltd. Earnings and Revenue History